Press Releases | Medtronic

Month Year

Email alerts

Oct 5, 2010

2010 Medtronic Twin Cities Marathon "Global Heroes" Celebrate Accomplishment

Extraordinary Runners from Around the World Complete Medtronic Twin Cities Marathon Events with Help from Medical Technology

MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Twenty-four Medtronic Global Heroes, long-distance runners who benefit from medical technology, successfully completed either the Medtronic Twin Cities...
Oct 5, 2010

Medtronic Announces New Curette for Treatment of Vertebral Compression Fractures

MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced the launch of the new KYPHON(R) Express(TM) Curette for scraping or scoring bone in the spine, including...
Oct 1, 2010

Medtronic Extends Sponsorship of Medtronic Twin Cities Marathon

MINNEAPOLIS, Oct 01, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Twin Cities In Motion (formerly Twin Cities Marathon, Inc.) announced they have signed a letter of intent to continue...
Sep 28, 2010

Medtronic's Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients

Reveal(R) Plus Study Results Published Today in Circulation

MINNEAPOLIS, Sep 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of results from a multicenter, prospective study that demonstrated that the company's Reveal(R)
Sep 28, 2010

Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease

Data from 1,500-Patient IN.PACT(TM) Clinical Program Presented at TCT; First Patient Enrolled in European Study on Device's Use in SFA Disease

WASHINGTON, Sep 28, 2010 (BUSINESS WIRE) -- Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc. (NYSE: MDT), today announced...
Sep 23, 2010

Medtronic Initiates Global Commitment to Address Burden of Non-Communicable Disease

Announced at Clinton Global Initiative, an initial $1 million in grants are part of an overall strategic effort to reduce the burden of chronic disease

MINNEAPOLIS, Sep 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. today announced at the Clinton Global Initiative a $1 million commitment to the NCD Alliance. The grants are made in preparation for...
Sep 20, 2010

Medtronic Receives FDA Approval of Integrity(R) Coronary Stent

Superior Deliverability Distinguishes New Medical Device Based on Engineering Advance of Continuous Sinusoid Technology

MINNEAPOLIS, Sep 20, 2010 (BUSINESS WIRE) -- Delivering another innovation for interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA)...
Sep 20, 2010

Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study

Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device

WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
Sep 17, 2010

Newly Published Data Show Occipital Nerve Stimulation May Be a Promising New Therapy for Chronic Migraine

Initial Results Suggest ONS Warrants Further Study for Control of Chronic Migraine

MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...
Sep 17, 2010

Medtronic Showcases Cardiovascular Devices at TCT 2010

Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...

Show per page